216 Tissue nanomechanical signature as a novel, clinically translatable predictor of response to immunotherapy combined with low-dose radiation

• James Welsh,
• Vittorio Cristini,
• Mark Wasley,
• Joylise Mitchell,
• Nahum Puebla-Osorio,
• Ailing Huang,
• Sara Nizzero,
• Gitika Srivastava,
• Thomas Riad,
• Papa Diogop Ndiaye,
• Mariam Gachechiladze,
• Philipp Oertle,
• Tobias Appenzeller,
• Marko Loparic,
• Marija Plodinec

Affiliations

James Welsh

3The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Vittorio Cristini

19 Mathematics in Medicine Program, The Houston Methodist Research Institute, Houston, Texas, USA

Mark Wasley

1MD Anderson Cancer Center, Houston, TX, USA

Joylise Mitchell

1MD Anderson Cancer Center, Houston, TX, USA

Nahum Puebla-Osorio

1MD Anderson Cancer Center, Houston, TX, USA

Ailing Huang

1MD Anderson Cancer Center, Houston, TX, United States

Sara Nizzero

1ARTIDIS AG, Basel, Switzerland

Gitika Srivastava

1ARTIDIS AG, Basel, Switzerland

Thomas Riad

3The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Papa Diogop Ndiaye

1ARTIDIS AG, Basel, Switzerland

Mariam Gachechiladze

1ARTIDIS AG, Basel, Switzerland

Philipp Oertle

1ARTIDIS AG, Basel, Switzerland

Tobias Appenzeller

1ARTIDIS AG, Basel, Switzerland

Marko Loparic

1ARTIDIS AG, Basel, Switzerland

Marija Plodinec

1ARTIDIS AG, Basel, Switzerland